Launch of guidance for best practices for clinical trials

The purpose of this virtual event is to engage and inform key stakeholders about the newly developed WHO guidance on best practices for clinical trials. Through this launch, we aim to build awareness, encourage adoption, and foster collaboration among stakeholders to elevate the quality and integrity of clinical research globally. Please register for the event using this link.  It takes place on 25 September 2024, 13:00 – 14:30 CET. 

Event objectives

• Inform: Disseminate the new guidance to all relevant stakeholders.
• Engage: Involve stakeholders in discussions on the added value and practical implications of the guidance.
• Adopt: Encourage the integration of the guidance into clinical trial practices across diverse settings.
• Collaborate: Facilitate partnerships that support the implementation and continuous improvement of the guidance.

This event is designed for a wide range of stakeholders, including:

• Policymakers: Government agencies, regulatory bodies, and international organizations responsible for healthcare policies and regulations, including WHO.
• Clinical trial regulators: Authorities overseeing the approval and monitoring of clinical trials.
• Funders: Public and private organizations that provide financial support for clinical research.
• Researchers: Academics and industry professionals conducting clinical trials.
• Civic society and patient Groups: Organizations and advocates representing patient interests and public welfare.
• Ethicists: Professionals dedicated to ensuring that clinical trials are conducted with the highest ethical standards.